Gracell Biotechnologies Inc. (GRCL)
$0.00 $0.00 (0.00%) 12:07 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$989.87M -
Day's Range
- - - -
Volume
- -
52 Week Low / High
$4.66 - $10.44 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
GRCL's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $12.50
- Target Price
Company News
-
Gracell Biotechnologies Inc. Further expands clinical development of FasTCAR-T GC012F in multiple myeloma amid ongoing U.S. trial evaluating therapy for treatment of relapsed/refractory multiple myeloma SAN DIEGO and SUZHOU, China and SHANGHAI, China, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gr...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$